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The respiratory and gastrointestinal tracts (GIT) share common embryological origins and an 2 
intriguing, and commonly revisited, question is “do processes occurring somewhere along the length 3 
of the GIT cause asthma symptoms?”  Gastroenterologists have been known to remind their 4 
pulmonology colleagues that the lungs are actually the larger of two appendices of the 5 
gastrointestinal tract.  Might it be feasible that processes taking place in the GIT may cause 6 
respiratory symptoms?   7 
There is no doubt that exposure of the upper GIT to peanuts in sensitised individuals can lead to 8 
asthma-like symptoms.  Based on work done in animals, there is the plausible mechanism whereby 9 
acid in the oesophagus might cause cough via to gastro-respiratory neural connections but in 10 
humans, acid suppression does not improve asthma symptoms [1].  But what about asthma 11 
causation de novo? The only interventions to prevent the development of asthma included a 12 
multifaceted intervention which included prolonged breastfeeding, delayed weaning in infants and 13 
elimination of common food allergens until 12 months of age in those at increased risk for 14 
developing asthma [2,3]. So might GI exposures cause asthma? And if so by what mechanism?  15 
The advent of techniques for describing whole communities of bacteria has led to considerable 16 
research activity which explores whether bacteria normally resident within humans (the 17 
microbiome) may be causally related to asthma. In the respiratory tract, asymptomatic 18 
nasopharyngeal carriage of Streptococcus, Haemophilus and Moraxella has been associated with 19 
increased risk for later asthma symptoms [4] and bronchial dysbiosis (i.e. an atypical bacterial 20 
community in the airways characterised by an increased burden of Proteobacteria) is associated with 21 
established asthma [5].  The GI microbiome may also be relevant to the development of asthma by 22 
acting as a source of lower airway bacterial colonisation and/or by influencing the development of 23 
atopy and/or by a “common mucosal response” (i.e. cross-talk between mucosal surfaces) [5]. The 24 
figure summarises these proposed mechanisms. 25 
Proving whether the GI microbiome might cause asthma is a huge challenge for many reasons, 1 
including sampling at the correct time in the life course and analysing the complex GI microbiome.  2 
Additionally there are the usual epidemiological challenges of confounding (e.g. by smoking, 3 
poverty, diet), reverse causation, bias in recruitment, loss to follow-up and small sample size leading 4 
to false positive findings.  In addition to these seemingly endless hurdles, there is no gold standard 5 
definition of asthma.   6 
There are at least three ways to overcome some of these challenges and improve our understanding 7 
of asthma microbiome biology: (i) explore biological mechanisms to support direct 8 
causation/pathogenesis (ii) explore the disease longitudinally, preferably commencing pre-morbidly, 9 
to ensure signals are consistent throughout and (iii) analyse microbial signals with respect to 10 
objective disease markers longitudinally to demonstrate mathematical correlation as the disease 11 
flares or remits over time and with treatment. The landmark study of Arrieta and colleagues [6] is an 12 
excellent example of the first of these approaches in this field; here five GIT bacterial genera 13 
(Veillonella, Lachnospira, Rothia, Faecalibacterium and Bifidobacterium) were associated with a 14 
lower incidence of atopy and wheeze in infants, and so presumed to be associated with protection 15 
from asthma development. The offspring of mice colonised with these organisms were then shown 16 
to have ameliorated airway inflammation in an ovalbumin stimulation experiment. Whilst the 17 
mechanism of protection was not identified in this study, it neatly demonstrated a biological link 18 
between the organisms detected in a population study and protection against the clinical outcome 19 
associated in an animal model. The ongoing Genetics, Environment, Microbial Project in 20 
inflammatory bowel disease is a good example of the second approach [7].   The study by Quince et 21 
al [8] is an example of the third approach and links longitudinal changes to the microbiome in 22 
Crohn’s disease before and after exclusive enteral nutrition and compares this change to an index of 23 
disease activity (calprotectin). 24 
An article published in this edition of the Journal of Allergy and Clinical Immunology [9] has taken the 1 
first of the above approaches and explored the relationship between the GIT microbiome and faecal 2 
metabolome (i.e. small molecules encompassing metabolites produced by the host, the gut 3 
microbes or derived from diet) and asthma symptoms at age three years.  In a cross-sectional 4 
analysis, using samples from 361 participants in a birth cohort initially numbering 806, the authors 5 
found associations between asthma symptoms and increased abundance in stool samples of the 6 
Christensenellaceae family, and also with reductions in 45 metabolomic signals (placed in 11 7 
clusters) which were detected in the plasma.  Following adjustment for multiple testing, associations 8 
between asthma and metabolites remained significant for only five molecules.  The authors noted 9 
no associations between asthma and other bacterial populations nor between asthma and the 692 10 
other molecules detected.  There were associations between a diet rich in meat and some 11 
metabolites.  In the longitudinal analysis breast feeding was associated with 11 plasma metabolites 12 
at three years associated, and some of these metabolites were also associated with current asthma 13 
symptoms; these metabolites explained approximately 20% of the apparently protective relationship 14 
between breastfeeding and asthma (odds ratio 0.36 in this cohort). Although the authors claim to 15 
have integrated omics datasets, their analyses relied on multiple correlations. 16 
The paper by Lee-Sarwar [9] raises more questions than it answers, particularly in the context of 17 
metabolome.  For example, it is plausible that blood metabolome in three year olds may be truly 18 
related to historical breast feeding since what you eat today will affect your blood metabolome 19 
within the next 30 to 5 hours only and your gut microbiome over the next two to four days? Did the 20 
plasma metabolites originate from gut microbes, the host or their diet? if so how many other 21 
metabolites were removed from the portal vein by the liver? the authors imply that several of their 22 
metabolites are microbially originating but that this is unlikely to be the case, particularly for PUFA 23 
which the gut microbiota are unlikely to produce.  In other conditions, metabolites are usually raised 24 
in association with chronic inflammation so why were metabolites reduced in association with 25 
asthma? An unexpected finding that Christensenellaceae is associated with increased symptoms 1 
since it is usually associated with reduced risk for other outcomes, particularly obesity[10].  2 
As one of the first in its field, only time will tell whether this was a well-done proof-of-concept study 3 
which informed future research towards novel insights into the development (and prevention) of 4 
asthma.  At this point in time, this remains a comprehensive assessment of the GI metabolome and 5 
GI bacterial community in the context of early asthma symptoms.  As the authors point out, this 6 
analysis needs replication in other populations since many findings may be false positive results.    7 
Finally, we should not forget our experience with Helicobacter pylori and peptic ulcer disease. The 8 
discovery of this one organism, colonising the previously unrecognised microbial niche of the human 9 
stomach, completely transformed the paradigm of a chronic inflammatory “non communicable” 10 
disease and often treated by major surgery such as partial gastrectomy or vagotomy. Peptic ulcers 11 
are now cured by acid suppression and a short course of antibiotics. One promise of microbiome 12 
research is the discovery of other such microbially-mediated diseases, with the prospect of similar 13 
paradigm shifts in prevention or therapy. Could asthma be a future candidate for such a change? 14 
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FIGURE LEGEND 2 
Schematic diagram summarising the possible mechanisms for the gastrointestinal bacterial 3 
community to cause asthma.  1. Common mucosal response, here shared properties of and cross-4 
talk between the large intestinal and respiratory mucosa lead to similar bacterial communities at 5 
both sites. 2. The intestinal bacteria directly influence the bacterial community in the lower airways 6 
(likely by fecal-oral transmission). 3. The metabolome, determined in part by lower intestinal 7 
bacteria, predisposes to asthma. 4. Lower intestinal bacteria stimulate immune deviation to an 8 
atopic TH2 phenotype during the neonatal and period which predisposes to asthma.  Any one or 9 
combination of these mechanisms (or none) may be active. 10 
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